Wells Fargo & Co. restated their hold rating on shares of EP Energy Corp (NYSE:EPE) in a report released on Thursday. EP Energy Corporation (NYSE:EPE) in last trading activity advanced 9.07% to close at $10.94. Company weekly performance is 44.90% while its quarterly performance stands at -36.98%. EP Energy Corporation (NYSE:EPE) is -52.91% away from its 52 week high.
ACADIA Pharmaceuticals (NASDAQ:ACAD) Director Mary Ann Gray sold 12,250 shares of ACADIA Pharmaceuticals stock on the open market in a transaction dated Monday, December 15th. The stock was sold at an average price of $31.74, for a total value of $388,815.00. On last trading day ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) decreased -6.42% to close at $30.17. Its volatility for the week is 5.39% while volatility for the month is 4.42%. ACAD’s sales growth for past 5 years was -7.20% and its EPS growth for past 5 years was 24.00%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) monthly performance is 6.12%.
U.S. President Barack Obama rebuked Sony Corp. Friday for caving in to North Korea’s cyber attacks by cancelling the release of the satirical film The Interview. He also addressed the issue of the Keystone XL pipeline, pouring cold water on what he called a “hyped” project of little benefit to Americans. Obama confirmed the attack on Sony’s computer system came from North Korea, adding no other country was involved. He also addressed the issue of the Keystone XL pipeline, pouring cold water on what he called a “hyped” project of little benefit to Americans. Obama confirmed the attack on Sony’s computer system came from North Korea, adding no other country was involved. Keystone project owner TransCanada Corporation (NYSE:TRP) issued a statement noting the pipeline project is designed to transport both Canadian and U.S. oil to markets. This includes oil from the Bakken fields in North Dakota. The company added Keystone is “not an export pipeline system – period.” TransCanada also noted the State Department has calculated the pipeline will create 42,100 direct and indirect jobs. On last trading day TransCanada Corp. (NYSE:TRP) advanced 2.48% to close at $48.79. Its volatility for the week is 2.85% while volatility for the month is 2.84%. TRP’s sales growth for past 5 years was 0.60% and its EPS growth for past 5 years was -1.20%. TransCanada Corp. (NYSE:TRP) monthly performance is -3.77%.
Analysts at Bank of America reiterated a “buy” rating on shares of LGI Homes, Inc. (NASDAQ:LGIH) in a research note on Thursday, December 4th. LGI Homes, Inc. (NASDAQ:LGIH) has 12.80% insider ownership while its institutional ownership stands at 51.50%. In last trading activity company’s stock closed at $14.95.
Roughly four months after Roche acquired Santaris Pharma, the locked nucleic acid drugmaker — now known as Roche Innovation Center Copenhagen (RICC) — has transitioned into the centerpiece of the Roche’s return to RNA therapeutics. And while RICC is tasked primarily with discovering targets and developing new LNA-based drugs against them, it has already yielded its first clinical candidate in one of Santaris’ existing drugs, according to a company official. Formerly known as SPC2968, the drug — now called RG6061 — was previously under development with Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), but Santaris regained full ownership of the compound last year when that partnership ended. On Tuesday shares of Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) closed at $1.02. Company’s sales growth for last 5 years was -9.60%.